TORONTO, Feb. 21, 2013 /CNW/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, announced today that it will report its fiscal 2013 first quarter financial results on Friday, March 8, 2013.
In conjunction with the company's financial results announcement, Patheon will host a conference call and webcast on Friday, March 8, 2013 at 10 a.m. Eastern Time. The financial results news release will be issued at approximately 7 a.m. Eastern Time on Friday, March 8, 2013.
Interested parties are invited to access the conference call, via telephone, in listen-only mode, toll-free at 1-888-231-8191 (U.S., including Puerto Rico) and 1-647-427-7450 (Canada and international). Listeners are encouraged to dial in five to fifteen minutes in advance to avoid delays. Slides will also be available for viewing during the call by accessing http://ir.patheon.com/events.cfm.
A telephone replay of the conference call will be available between Friday, March 8, 2013 and Friday, March 15, 2013 by dialing 1-855-859-2056 (toll-free) or 1-403-451-9481, and by entering identification number 99069353, followed by the number key. The webcast and slides will be archived at http://ir.patheon.com/events.cfm.
About Patheon Inc.
Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company's recent acquisition of Banner Pharmacaps - a market leader in soft gelatin capsule technology - Patheon now also includes a proprietary products and technology business.
Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. The company's integrated network consists of 18 locations, including 14 commercial contract manufacturing facilities and 12 development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit www.patheon.com.
SOURCE: Patheon Inc.
Senior Representative, Corporate Communications & Investor Relations
919 226 3200